(HHS) Harte Hanks - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4161962026
HHS EPS (Earnings per Share)
HHS Revenue
HHS: Marketing Services, Customer Care, Fulfillment, Logistics, Outsourcing
Harte Hanks Inc (NASDAQ:HHS) is a customer experience company that provides a comprehensive suite of services to drive business growth for its clients across various industries. By leveraging its expertise in data and analytics, research, strategy, creative and content, and marketing technology, the company enables businesses to develop and execute effective omnichannel marketing strategies, enhance customer experience, and improve overall marketing ROI.
The companys diversified service offerings span across three primary segments: Marketing Services, Customer Care, and Fulfillment and Logistics. Its Marketing Services segment provides a range of capabilities, including data-driven marketing, research, and strategy development, as well as creative and content creation, marketing technology, and digital and multi-channel marketing execution. The Customer Care segment offers inside sales outsourcing, lead generation, and customer service outsourcing, while the Fulfillment and Logistics segment provides product fulfillment, print-on-demand, and third-party logistics services.
With a presence in the United States and internationally, Harte Hanks serves a diverse client base across industries such as B2B, healthcare, pharmaceuticals, financial, automotive, and retail. The companys long history, dating back to 1923, and its headquarters in Chelmsford, Massachusetts, underscore its established position in the market. For more information, visit https://www.hartehanks.com.
Analyzing the
Additional Sources for HHS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
HHS Stock Overview
Market Cap in USD | 30m |
Sector | Industrials |
Industry | Conglomerates |
GiC Sub-Industry | Advertising |
IPO / Inception | 1993-11-04 |
HHS Stock Ratings
Growth Rating | -5.13 |
Fundamental | -30.7 |
Dividend Rating | 16.5 |
Rel. Strength | -61.1 |
Analysts | 5 of 5 |
Fair Price Momentum | 3.35 USD |
Fair Price DCF | - |
HHS Dividends
Currently no dividends paidHHS Growth Ratios
Growth Correlation 3m | -66.9% |
Growth Correlation 12m | -97.1% |
Growth Correlation 5y | 20% |
CAGR 5y | 5.61% |
CAGR/Max DD 5y | 0.07 |
Sharpe Ratio 12m | -0.77 |
Alpha | -57.72 |
Beta | 0.236 |
Volatility | 77.96% |
Current Volume | 26.7k |
Average Volume 20d | 9.8k |
As of July 01, 2025, the stock is trading at USD 3.98 with a total of 26,665 shares traded.
Over the past week, the price has changed by +13.39%, over one month by -12.53%, over three months by -17.08% and over the past year by -51.76%.
Probably not. Based on ValueRay´s Fundamental Analyses, Harte Hanks (NASDAQ:HHS) is currently (July 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -30.74 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HHS is around 3.35 USD . This means that HHS is currently overvalued and has a potential downside of -15.83%.
Harte Hanks has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy HHS.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, HHS Harte Hanks will be worth about 3.6 in July 2026. The stock is currently trading at 3.98. This means that the stock has a potential downside of -9.05%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 17.5 | 339.7% |
Analysts Target Price | 16.5 | 314.6% |
ValueRay Target Price | 3.6 | -9% |